T-cell Acute Lymphoblastic Leukemia Clinical Trials in Shenzhen, Guangdong
2 recruitingShenzhen, Guangdong, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
Universal 4SCAR7U Targeting CD7-positive Malignancies
Acute Myeloid LeukemiaT-cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Shenzhen Geno-Immune Medical Institute30 enrolled1 locationNCT05995028
Recruiting
Phase 1Phase 2
Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
T-lymphoblastic LymphomaRelapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/Refractory B-cell Non-Hodgkin Lymphoma or CLL/SLL+3 more
Beijing Biotech96 enrolled1 locationNCT07523555